February 4, 2012
| Bio-IT World > R Is Ready to Rumble


R Is Ready to Rumble


INside the Box - Bill van Etten

July 14, 2004 | Anyone who's done it knows that microarray analysis can be computationally intensive. However, much of the microarray analysis software out there is proprietary, runs only on Windows, and executes as a single process on a single machine (not very scalable). The BioTeam was recently asked to implement a free, open-source, cross-platform, and cluster-enabled solution for high-performance microarray analysis. As part of the solution, we made use of R and several R packages from BioConductor. We thought we should share some of what we learned.


What is R? 
Grossly oversimplified, R is what you use when your data analysis and plotting requirements exceed the functionality of Excel but you don't want to buy a commercial package. R is rapidly gaining widespread acceptance, use, and utility within the bioinformatics community due to its rich functionality, open-source licensing, ease of extensibility, and broad developer support from a worldwide community.

R is both an interpreted programming language and an application environment for the performance of statistical computing and graphing. It consists of a language, run-time environment, graphics engine, and debugger, and it has the ability to execute stored R scripts. R is available for free under the terms of the Free Software Foundation's GNU General Public License in source-code form, and it compiles and runs on a wide variety of Unix-based platforms (including FreeBSD, Linux, and Mac OS X) and Windows.

The R language allows branching, looping, and modular programming using functions. Built-in R user functions are written in R; however, it is possible for the user to provide an interface to procedures written in C, C++, or Fortran for higher performance.


R IS FOR RENDER: R incorporates functions to generate a variety of graphs and plots. Shown here are a few examples of the package's data presentation capabilities.
The core R distribution provides a wide variety of statistical functions, including linear and nonlinear modeling, time series analysis, parametric and nonparametric tests, clustering, and smoothing. Also, many functions provide a flexible graphical environment for publication-quality data presentations in many common graphics formats.

In addition to the R core, R is easily extended through the network-based installation of additional modules (add-on packages) that are available for a variety of specific purposes.

R users have available to them the Comprehensive R Archive Network, with several hundred user-contributed packages ranging from abind (combines multidimensional arrays) to zoo (methods for ordered indexed observations).

Two other large open-source R package repositories of note are Omegahat and BioConductor. The Omegahat packages extend R with intersystem interfaces to things like Java, Perl, Python, and CORBA. BioConductor provides nearly 100 packages that extend R for bioinformatics research ranging from rendering annotations of public genomic data to microarray analysis.

The minimal graphical user interface to R (for Linux, Mac OS X, and Windows) provides a console within a window and menus for basic functions. However, to get the most from R, the user operates either through the built-in shell command interpreter or through command-line execution of text-edited R scripts. The command-line interface makes it rather trivial to submit and execute R scripts over a scalable cluster architecture using a distributed resource management system, such as Sun GridEngine.

With all the components in place, the few remaining bits involve parallelizing the R code for high performance, which we'll leave as an exercise for the reader.



Bill Van Etten is a consultant for The BioTeam. E-mail: bill@bioteam.net. 




White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .